Approving additional brands of Covid-19 vaccines in South Africa would help counter any future disruptions in the country’s vaccine roll-out.

This, according to Professor Gregory Hussey, of the Faculty of Health Sciences, at the University of Cape Town.

Hussey welcomed the news that, except for the Johnson & Johnson and Pfizer-vaccines, other brands of vaccines may soon be introduced here.

He says the global demand for vaccines will, for a while still, cause strain on vaccine-supply to especially African countries.

The Department of Health recently said that the Sinovac vaccine has been provisionally approved for use in the country, while the Astra-Zeneca may also, in future, be used here again.

Access the latest Western Cape digicon here.

Related articles:

The World Health Organization (WHO) has approved China’s Sinovac Covid-19 vaccine for emergency use.

The Organization says it will now be able to significantly boost its supply of vaccines to the Covax-facility, after green-lighting the use of the vaccine.

The WHO’s prof. Katherine O’Brien says clinical trials have shown that up to 51% of people – vaccinated with Sinovac – developed a less severe form of the virus.

O’Brien says this is the second Chinese vaccine, after Sinopharm, to receive WHO-approval.

Read more here.

Related articles: